: an unusual cause of acute and chronic cough in the Caribbean area.

https://bit.ly/3qnemv9.

Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors.

Purpose: The metabolic changes associated with cachexia - sarcopenia syndrome might down-regulate antitumor immunity. We hypothesized that this syndrome reduces efficiency of immune checkpoint inhibitors (ICPI) in non-small cell lung cancer (NSCLC).

Methods: The records of 142 consecutive NSCLC patients receiving first- or second-line anti-Programmed cell death protein 1) ICPI were reviewed.

Synchronous multiple non-small cell lung cancers in an allograft lung recipient.

We described a case report of synchronous non-small cell lung cancers arising in lung transplants after allograft. Immunosuppressive therapy of the recipient induced an accelerated growth rate of primary tumour and metastases as was been observed in orthotopic liver allograft for hepatocellular carcinoma.